Role of advanced glycation end products and their receptors in development of diabetic neuropathy

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 598-604

  Wada, Ryuichi ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Advanced glycation end product; Diabetes; Microangiopathy; Neuropathy; Receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; POLYOL;

ANIMAL TISSUE; AUTONOMIC NERVE; BLOOD LEVEL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GENE EXPRESSION; HYPERGLYCEMIA; NERVE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NERVE; PROTEIN GLYCOSYLATION; RAT; SCHWANN CELL; TARGET ORGAN; TISSUE INJURY; VASCULAR DISEASE;

EID: 23744467294     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.067     Document Type: Conference Paper

References (30)

1. GREENE, D.A. & S.A. LATTIMER. 1983. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J. Clin. Invest. 72: 1058-1063.
2. +)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats. Diabetologia 42: 743-747.
3. WADA, R. et al. 2001. Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy. Eur. J. Clin. Invest. 31: 513-520.
4. SUAREZ, G. et al. 1988. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats. J. Clin. Invest. 82: 624-627.
5. HAMADA, Y. et al. 2000. Epalrestat, an aldose reductase inhibitor, reduces the levels of Nε-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care 23: 1539-1544.
6. BROWNLEE, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
7. HAMMES, H.P. et al. 2003. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9: 294-299.
8. STRACKE, H. et al. 2001. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp. Clin. Endocrinol. Diabetes 109: 330-336.
9. KARACHALIAS, N. et al. 2003. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem. Soc. Trans. 31: 1423-1425.
10. VLASSARA, H., M. BROWNLEE & A. CERAMI. 1981. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc. Natl. Acad. Sci. USA 78: 5190-5192.
11. WILLIAMS, S.K. et al. 1982. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc. Natl. Acad. Sci. USA 79: 6546-6550.
12. MONNIER, V.M., R.R. KOHN & A. CERAMI. 1984. Accelerated age-related browning of human collagen in diabetes mellitus. Proc. Natl. Acad. Sci. USA 81: 583-587.
13. TARSIO, J.F. et al. 1985. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus. Diabetes 34: 477-484.
14. SUGIMOTO, K. et al. 1997. Localization in human diabetic peripheral nerve of Nε-carboxymethyllysine-protein adducts, an advanced glycation endproduct. Diabetologia 40: 1380-1387.
15. SCHMIDT, A.M. et al. 1992. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267: 14987-14997.
16. WADA, R., & S. YAGIHASHI. 2004. AGEs and diabetic neuropathy [in Japanese]. In AGE Research. T. Imaizumi & S. Yamagishi, Eds.: 109-119. Medical Review. Osaka.
17. TAKEUCHI, M. et al. 2000. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J. Neuropathol. Exp. Neurol. 59: 1094-1105.
18. SEKIDO, H. et al. 2004. Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells. Biochem. Biophys. Res. Commun. 320: 241-248.
19. + ATPase impairment and experimental glycation: the role of glucose autooxidation. Free Radic. Res. 24: 381-389.
20. BUCALA, R., K. J. TRACEY & A. CERAMI. 1991. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87: 432-438.
21. AMORE, A. et al. 1997. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int. 51: 27-35.
22. CHAKRAVARTHY, U. et al. 1995. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr. Eye Res. 14: 285-294.
23. SCHMIDT, A.M. et al. 1994. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad Sci. USA 91: 8807-8811.
24. YAN, S.D. et al. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269: 9889-9897.
25. SCHMIDT, A.M. et al. 1995. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96: 1395-1403.
26. YAMAMOTO, Y. et al. 2001. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108: 261-268.
27. SIMA, A.A. & K. SUGIMOTO. 1999. Experimental diabetic neuropathy: an update. Diabetologia 42: 773-788.
28. KIHARA, M. et al. 1991. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. USA 88: 6107-6111.
29. YAGIHASHI, S. et al. 1992. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41: 47-52.
30. SUGIMOTO, K. & S. YAGIHASHI. 1997. Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc. Res. 53: 105-112.